NHS DigiTrials: how the search for COVID-19 treatments is revolutionising clinical trials The UK health service’s data-led approach to trials has helped to save millions of lives from COVID-19 worldwide — here’s how the NHS is setting an exciting new blueprint for all clinical trials.…
Knowing how to read research papers makes us better pharmacists, so I started a journal club When she noticed that colleagues were uncomfortable with research papers, meaning they were locked out of clinical conversations, community pharmacist Iqra Sarwar took action.…
Conflicting regulations on controlled drugs may expose pharmacists to criminal liability — the law must change Contradictions in misuse of drugs regulations mean there are ways in which pharmacists dispensing controlled drugs could be seen to be breaking the law. Two decades after their last revision, these regulations are surely due a rethink.…
RPS commits to proactive anti-racism The Royal Pharmaceutical Society has made 11 commitments as part of its anti-racism pledge.…
RPS joins APTUK and NHS England to launch action plan for inclusive pharmacy practice The joint plan will include actions that pharmacy teams should incorporate into practice to “benefit the health of our diverse communities”.…
Pharmacy regulator to publish ‘diversity data’ around fitness-to-practise cases The General Pharmaceutical Council has said it will publish diversity data related to fitness-to-practise cases in order to understand and address potential discrimination.…
RECOVERY trial halts recruitment to colchicine arm because of a lack of ‘convincing’ evidence The anti-inflammatory drug colchicine has shown no significant difference in improving survival rates from usual care in patients with COVID-19.…
RPS Museum online exhibition celebrates women in pharmacy 'Celebrating Women in Pharmacy' launched on International Women's Day and celebrates women throughout the history of pharmacy.…
New drug cuts the risk of death in bladder cancer by 30% compared with chemotherapy, study suggests A trial comparing new antibody-drug conjugate enfortumab vedotin with chemotherapy in patients with bladder cancer has found that overall survival was longer in the group receiving the new drug.…
Half of asthma patients in the UK overusing SABAs, study finds In a UK asthma programme, 284,683 out of 574,913 patients were found to be “potentially overusing” short-acting β2-agonists.…
